News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cannell Thomas R
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/06/2023 |
4
| Cannell Thomas R (President and CEO) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Sold 208,923 shares
@ $0.587, valued at
$122.6k
Exercised 606,800 shares
@ $0.587, valued at
$356.2k
Sold 278,564 shares
@ $0.587, valued at
$163.5k
|
|
| 02/23/2023 |
4
| Cannell Thomas R (President and CEO) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Sold 53,727 shares
@ $0.5873, valued at
$31.6k
|
|
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2017 |
4
| Cannell Thomas R (EVP, COO, Pres Global Com Prod) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 2,119 shares
@ $1.55, valued at
$3.3k
|
|
| 02/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|